Onychomycosis Treatment Market Size, Share, Growth Analysis, By Treatment Type (Drugs, Lasers), By Disease Indication (Distal Subungual Onychomycosis, White Superficial Onychomycosis), By Age Group (18 to 39 Years, 40 to 64 Years), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales), By Region - Industry Forecast 2025-2032

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to the growing cases of onychomycosis due to many factors like growing prevalence of diabetes, ageing population, and lifestyle changes, especially in the leading nations like Canada and the United States. The growing awareness among the patients and the medical professionals regarding fungal infections of nail is notably contributing to the increased diagnosis and the number of treatment rates. The region is also benefitted by the high-tech healthcare infrastructure, comprising easy access to many treatment options and advanced diagnostic technologies. The key players operating in the region include Bausch Health Companies Inc., Pfizer Inc., Johnson & Johnson Services, Inc. and more.

The onychomycosis treatment market in Asia-Pacific is seen as the fastest-growing region among others due to the growing population diagnosed with onychomycosis and the rising number of patients. Asia-Pacific is witnessing diverse population, comprising nations with higher populations like India and China. This growing population is contributing to the major number of incidences of onychomycosis, thus impacting the treatment demand. Also, rising cases of onychomycosis are growing due to climate conditions, changing lifestyle, and the growing diabetic population. These factors along with enhancing healthcare infrastructure in the region are fueling the market growth.